Whalegun
Home

Robert J. Gould, Interim President & CEO: Fulcrum Therapeutics FULC Sell · Filed 23/01/13

Trade details

Type
Insider sale
Amount
$101,490
Shares · price
6,766 sh · $15.00 a share
Held after
499,864 sh
Stock
Fulcrum Therapeutics FULC
Person
Robert J. GouldInterim President & CEO
Trade date
23/01/13
Filed
23/01/13
Days to filing
0 days

Sold 1.3% of holdings

Share of holding sold
1.3%

Fulcrum Therapeutics trades, last 26 weeks

What else happened in Fulcrum Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/14~23/02/12

Robert J. Gould's recent trades

  • Robert J. Gould

    SellFulcrum Therapeutics

    $163.1K

    Filed 02/04

  • Robert J. Gould

    SellFulcrum Therapeutics

    $160.8K

    Filed 02/04

  • Robert J. Gould

    SellFulcrum Therapeutics

    $178.1K

    Filed 01/06

  • Robert J. Gould

    SellFulcrum Therapeutics

    $165.5K

    Filed 25/11/21

  • Robert J. Gould

    Planned sale10b5-1 planFulcrum Therapeutics

    $437.9K

    Filed 25/11/19

Robert J. Gould, CEO — sold $101.5K of Fulcrum Therapeutics FULC · 1.3% of holdings | Whalegun